Oncology dealmaking fuels biotech M&A | White & Case LLP

Global spending on cancer medicines is set to reach US$375 billion by 2027, with innovation in drug discovery and development ramping up to meet rising demand. While the global biotech...

Related Keywords

California ,United States ,Massachusetts ,Boston ,China ,France ,French ,Bristol Myers Squibb ,Pionyr Immunotherapeutics ,Ambrx Biopharma ,Eli Lilly ,White Case ,Johnson ,Citius Pharmaceuticals ,Nvidia ,Cour Pharmaceuticals ,Amgen ,Novartis ,Bloomberg ,Nasdaq ,Mirati Therapeutics ,Karuna Therapeutics ,Ratio Therapeutics ,Accent Therapeutics ,Harpoon Therapeutics ,Revolution Medicines ,Ikena Oncology ,Fierce Biotech ,Tenx Acquisition ,